Identification of drug candidates which increase cytochrome c oxidase activity in deficient patient fibroblasts

被引:5
作者
Maj, Mary [1 ,2 ]
Sriskandarajah, Niroshan [1 ]
Hung, Vinci [1 ]
Browne, Ikennah [1 ]
Shah, Bhavank [1 ]
Weadge, Anita [1 ]
Jamieson, Nicola L. [1 ]
Tropak, Michael [3 ]
Cameron, Jessie M. [1 ]
Addis, Jane B. [1 ]
Robinson, Brian H. [1 ,4 ,5 ]
机构
[1] Hosp Sick Children, Res Inst, Metab Res Programme, Toronto, ON M5G 1X8, Canada
[2] Hosp Sick Children, Dept Paediat Lab Med, Toronto, ON M5G 1X8, Canada
[3] Hosp Sick Children, Res Inst, Lysosomal Res Programme, Toronto, ON M5G 1X8, Canada
[4] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada
[5] Univ Toronto, Dept Paediat, Toronto, ON M5S 1A8, Canada
关键词
Cytochrome c oxidase; Mitochondria; High-throughput; Live cell assay; Chemical library screen; MITOCHONDRIAL RESPIRATORY-CHAIN; CELL-LINES; ACETYLATION; PGC-1-ALPHA; ACTIVATION; DEFECTS; ROSIGLITAZONE; BIOGENESIS; PROTEINS; BETULIN;
D O I
10.1016/j.mito.2010.10.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Cytochrome c oxidase (COX) activity reflects the expressed level of respiratory chain complexes, mtDNA levels, titer and mass of mitochondria. Activity is also indicative of the overall fitness of mt-transcription factors and the import, transcription and translation of mt-proteins. We have developed a high-throughput assay to measure COX activity using live cells to screen chemical libraries for compounds capable of increasing COX activity. These libraries have revealed four examples which elevated the activities of COX in NIH-3T3 fibroblasts and in fibroblasts from patients with COX defects independent of the peroxisome proliferator activated receptor family. (C) 2010 Elsevier B.V. and Mitochondria Research Society. All rights reserved.
引用
收藏
页码:264 / 272
页数:9
相关论文
共 34 条